|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,670 GBX | +1.03% |
|
+1.86% | +15.16% |
| 01:29pm | GSK : UBS reaffirms its Buy rating | ZD |
| 08:52am | Hipgnosis Songs Fund backs new Blackstone bid | AN |
April 16 (Reuters) - GSK plc:
* PRESCRIPTION DRUG USER FEE ACT ACTION DATE SET BY FDA FOR 14 FEBRUARY 2025
* FDA ACCEPTS GSK MENINGITIS VACCINE CANDIDATE FILE
* SUBMISSION BASED ON RESULTS FROM PIVOTAL PHASE III TRIAL SHOWING ALL PRIMARY ENDPOINTS MET Source text for Eikon: Further company coverage:
| 1st Jan change | Capi. | |
|---|---|---|
| +15.16% | 84.13B | |
| +25.78% | 661B | |
| +26.74% | 566B | |
| -6.65% | 352B | |
| +18.97% | 332B | |
| +3.17% | 283B | |
| +13.43% | 231B | |
| +4.71% | 200B | |
| -9.53% | 195B | |
| -4.15% | 145B |
GSK PLC 
